RILUZOLE News
RILUZOLE currently has 0 news articles, with 11 predicted indications.
This page combines the AI-predicted indications for RILUZOLE with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (11):
- amyotrophic lateral sclerosis (99.0%)
- bilateral parasagittal parieto-occipital polymicrogyria (100.0%)
- axial spondylometaphyseal dysplasia (100.0%)
- lower motor neuron syndrome with late-adult onset (100.0%)
- trichomegaly-retina pigmentary degeneration-dwarfism syndrome (100.0%)
- lethal arthrogryposis-anterior horn cell disease syndrome (100.0%)
- monomelic amyotrophy (100.0%)
- Mills syndrome (100.0%)
- amyotrophic lateral sclerosis, susceptibility to (100.0%)
- autosomal dominant mitochondrial myopathy with exercise intolerance (100.0%)
- amyotrohpic lateral sclerosis type 22 (100.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.